Company page

Rifampicin

Rifampicin is a public company focused on developing innovative treatments for infectious diseases. The company is dedicated to advancing its research and development efforts to address unmet medical needs. With a commitment to improving patient outcomes, Rifampicin aims to bring effective therapies to market.